Yes. The very first entry on the clinical trial site listed 50 patients as the target recruitment. Thereafter it was listed as 150 estimated.
But the company has lately referred to 120 patients. For example, the last FY report referred to a recruitment of 64 patients having “passed the mid-way point of 60”. They also said that they expected the recruitment to conclude this CY.
PNV Price at posting:
$2.57 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)